Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

NCT05150496 · clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
640
Enrollment
INDUSTRY
Sponsor class

Stopped The plan has changed

Conditions

Interventions

Sponsor

Sinovac Research and Development Co., Ltd.